Lyell Immunopharma, Inc. (LYEL) — Analyst estimates
Consensus analyst estimates for Lyell Immunopharma, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 4.25K | -2.29 | 1 |
| 2027 | 8.50K | -2.05 | 1 |
| 2028 | 56.65M | -7.07 | 3 |
| 2029 | 190.23M | -5.12 | 1 |
| 2030 | 280M | -4.07 | 1 |
Consensus analyst estimates by fiscal year.